FDA 483 OBSERVATION · #476 OF 1,000 MOST-CITED
Testing when laying hens 40 to 45 weeks
FDA cited this observation 51 times across 47 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.
What this observation is associated with
Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 3× the rate of the average FDA-cited firm (23.4% vs 7.7%), across 47 FEI-matched firms.
This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.
How FDA worded it — real examples
Environmental testing for SE, using approved methods, was not done in a poultry house when any group of laying hens constituting the flock was 40 to 45 weeks of age.
Environmental testing for SE, using approved methods, was not done in a poultry house when any group of laying hens constituting the flock was 40 to 45 weeks of age.
Environmental testing for SE, using approved methods, was not done in a poultry house when any group of laying hens constituting the flock was 40 to 45 weeks of age.
Environmental testing for SE, using approved methods, was not done in a poultry house when any group of laying hens constituting the flock was 40 to 45 weeks of age.
Environmental testing for SE, using approved methods, was not done in a poultry house when any group of laying hens constituting the flock was 40 to 45 weeks of age.
Environmental testing for SE, using approved methods, was not done in a poultry house when any group of laying hens constituting the flock was 40 to 45 weeks of age.
Related SPEQ references
Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.
Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.
Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.